Navigation Links
Philadelphia Native And Author Of Book On Healthcare Industry Headlines Expert Panel At The Wharton Health Care Business Conference
Date:2/7/2013

PHILADELPHIA, Feb. 7, 2013 /PRNewswire/ -- It's no secret that the healthcare landscape is tough and getting tougher.  In the U.S., we see the implementation of the healthcare reform against the background of a fragile economic recovery, creating a tumultuous environment for the entire sector.  Philadelphia native and author of Healthcare at a Turning Point: A Roadmap for Change Michael Abrams will moderate a panel discussion on how recent changes in the legal and regulatory landscape are impacting each sector of the industry at the Wharton Health Care Business Conference on February 15. 

Michael will be joined by panelists representing pharmaceuticals, medical devices, payers and healthcare IT to discuss how both domestic and global trends are impacting the entire healthcare sector.  This discussion will be followed by a Q&A with Michael and panelists Mitchell Higashi , PhD, Chief Economist, GE Healthcare , Joseph Leveque , MD, Vice President, Head of US Medical Oncology, Bristol-Myers Squibb, Matt Manders , President, Regional and Operations, Cigna, and Emad Rizk , MD, President McKesson Health Solutions, McKesson Corporation.  

This event is open to the media.

19th Annual Wharton Health Care Business Conference    
Hyatt at the Bellevue    
February 15, 2013    
11:15am-12:30pm

About Michael Abrams

Over the past 25 years, Michael has built a portfolio of strategy and business performance successes as both an internal and external consultant for Fortune 500 corporations on a global basis. Michael is well known for his expertise in the emerging demand for economic and clinical value, and has helped clients develop processes and capabilities to successfully compete in highly dynamic markets. Michael has written extensively on the need for integrated, systemic solutions to the challenges facing the healthcare industry, and has co-authored two books, including Healthcare at a Turning Point: A Roadmap for Change.

About Numerof & Associates:

NAI is a strategy consulting firm that develops customized, market-based solutions for strategic and operational challenges of organizations in industries undergoing significant transition. Working globally across the healthcare industry with clients in delivery, pharmaceuticals, medical devices and diagnostics, payers, and policy, NAI brings a unique cross-disciplinary approach to a broad range of engagements designed to sharpen strategic focus, increase revenues, reduce costs and risk, and enhance customer value. Visit us at www.nai-consulting.com.


'/>"/>
SOURCE Michael Abrams
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. $78.5 Million Jury Verdict In Philadelphia Birth Injury Case
2. Mike Golic, ESPN Radio Personality and Former Philadelphia Eagle, Holds Pre-Season "Training Camp" for People With Type 2 Diabetes
3. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
4. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
5. The Facelift Alternative by Nouveau Contour
6. Consumers Choosing Organic Alternatives to Traditional Pharmaceuticals
7. Elseviers MEDalternatives Offers Additional Cost Saving Options for Payers and Members
8. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
9. UBM Canon, the Global MedTech Authority, Announces Strategic Alliance with ITG Market Research, a Preeminent Industry Research Organization
10. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
11. Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research and Markets ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ... offering. ... drug delivery technologies will rise from USD 20 Billion in 2015 ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology:
(Date:4/28/2017)... Olathe, KS (PRWEB) , ... April 28, 2017 ... ... system have typically been previously exposed to more adverse experiences than children in ... have experienced trauma such as abuse, neglect or other family challenges. While no ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... the Creator responds to and which He does not. Yisrayl says with so many ... is the true name, but he says with a little Scripture, backed with a lot ...
(Date:4/28/2017)... ... 2017 , ... Intellitec Solutions announced the publication of a ... Dynamics GP solution that integrates to their PointClickCare EHR software package. With the ... Brooke Grove now has the capability to achieve its goal for a comprehensive ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that ... his presence to an educational purpose as the host of the “Informed” series. The ... In a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer ...
Breaking Medicine News(10 mins):